NLRP3 and Alzheimer disease: Taken together, the data in this study provide strong evidence that the acute, pharmacological inhibition of the NLRP3 inflammasome is well tolerated and can ameliorate neurodegeneration and loss of synaptic plasticity in a murine AD model.